Idiopathic hemi-facial lipoatrophy treated with autologous fat transfer

Facial lipoatrophy can be socially disfiguring, often prompting patients to seek correction. A variety of agents are used to treat facial lipoatrophy, but the quest for the ideal agent remains elusive. We present a case of non-HIV associated, idiopathic hemi-facial lipoatrophy successfully treated with autologous fat transfer (ATF). Because ATF has no complications from antigenicity, it is a safe and cost-effective treatment option for patients with non-HIV associated cases of facial lipoatrophy and abundant donor tissue.